Claire Russel 23/01/2024 Claire Russel 23/01/2024 Oncodesign Services, a major European CRO in preclinical Drug Discovery, majority-owned by ERES IV SLP, has acquired ZoBio. Nov Santé Actions Non Cotées, managed by Eurazeo, enters the Group’s capital Lire la suite Vincent Manes 10/01/2024 Vincent Manes 10/01/2024 ELYAN enters into exclusive negotiation to acquire a majority stake in STORDATA, the data management and security expert Lire la suite Claire Russel 12/10/2023 Claire Russel 12/10/2023 ERES IV, managed by Edmond de Rothschild Private Equity (France) and advised by Elyan, invests $30m in Decks & Docks, a US B2B distributor of marine construction and outdoor living supplies Lire la suite Claire Russel 29/06/2023 Claire Russel 29/06/2023 Tikamoon partners with a new shareholder to finance an ambitious growth strategy Lire la suite Maxence de Vienne 15/03/2023 Maxence de Vienne 15/03/2023 Edmond de Rothschild Private Equity and Elyan Partners raise over €500m for ERES IV - the fund will invest in midcap companies in Europe and North America Lire la suite Vincent Manes 26/10/2022 Vincent Manes 26/10/2022 ERES IV, advised by ELYAN PARTNERS, acquires a majority stake in ONCODESIGN SERVICES and will file a simplified tender offer on the company's remaining shares Lire la suite Maxence de Vienne 01/07/2022 Maxence de Vienne 01/07/2022 ELYAN PARTNERS enters into exclusive negotiations for the acquisition of a majority stake in the capital of ONCODESIGN (service) followed by the filing of a simplified takeover offer Lire la suite Vincent Manes 15/06/2022 Vincent Manes 15/06/2022 ERES invests in HungerRush Lire la suite Laure Lamm-Coutard 05/05/2022 Laure Lamm-Coutard 05/05/2022 ERES IV invests in Freightwise Lire la suite JF Felix 24/01/2022 JF Felix 24/01/2022 True Wind Capital and Elyan Partners Make Strategic Growth Investment in Envoy Global Lire la suite JF Felix 07/06/2021 JF Felix 07/06/2021 Reprise de la DNVB française Tikamoon à ADEO par ses dirigeants, avec le soutien d’ERES Lire la suite
Claire Russel 23/01/2024 Claire Russel 23/01/2024 Oncodesign Services, a major European CRO in preclinical Drug Discovery, majority-owned by ERES IV SLP, has acquired ZoBio. Nov Santé Actions Non Cotées, managed by Eurazeo, enters the Group’s capital Lire la suite
Vincent Manes 10/01/2024 Vincent Manes 10/01/2024 ELYAN enters into exclusive negotiation to acquire a majority stake in STORDATA, the data management and security expert Lire la suite
Claire Russel 12/10/2023 Claire Russel 12/10/2023 ERES IV, managed by Edmond de Rothschild Private Equity (France) and advised by Elyan, invests $30m in Decks & Docks, a US B2B distributor of marine construction and outdoor living supplies Lire la suite
Claire Russel 29/06/2023 Claire Russel 29/06/2023 Tikamoon partners with a new shareholder to finance an ambitious growth strategy Lire la suite
Maxence de Vienne 15/03/2023 Maxence de Vienne 15/03/2023 Edmond de Rothschild Private Equity and Elyan Partners raise over €500m for ERES IV - the fund will invest in midcap companies in Europe and North America Lire la suite
Vincent Manes 26/10/2022 Vincent Manes 26/10/2022 ERES IV, advised by ELYAN PARTNERS, acquires a majority stake in ONCODESIGN SERVICES and will file a simplified tender offer on the company's remaining shares Lire la suite
Maxence de Vienne 01/07/2022 Maxence de Vienne 01/07/2022 ELYAN PARTNERS enters into exclusive negotiations for the acquisition of a majority stake in the capital of ONCODESIGN (service) followed by the filing of a simplified takeover offer Lire la suite
Laure Lamm-Coutard 05/05/2022 Laure Lamm-Coutard 05/05/2022 ERES IV invests in Freightwise Lire la suite
JF Felix 24/01/2022 JF Felix 24/01/2022 True Wind Capital and Elyan Partners Make Strategic Growth Investment in Envoy Global Lire la suite
JF Felix 07/06/2021 JF Felix 07/06/2021 Reprise de la DNVB française Tikamoon à ADEO par ses dirigeants, avec le soutien d’ERES Lire la suite
